Vytrus Biotech, S.A. (BME:VYT)

Spain flag Spain · Delayed Price · Currency is EUR
12.80
+0.40 (3.23%)
At close: Feb 27, 2026
392.31%
Market Cap 96.31M
Revenue (ttm) 8.09M
Net Income (ttm) 1.95M
Shares Out 7.52M
EPS (ttm) n/a
PE Ratio 49.33
Forward PE 36.48
Dividend n/a
Ex-Dividend Date n/a
Volume 10,529
Average Volume 14,344
Open 12.80
Previous Close 12.40
Day's Range 12.40 - 13.00
52-Week Range 2.66 - 13.30
Beta 0.06
RSI 67.02
Earnings Date Mar 26, 2026

About Vytrus Biotech

Vytrus Biotech, S.A. develops, produces, and sells active ingredients from plant stem cells in Spain and internationally. The company offers Clarivine that activates skin’s regeneration processes; Quora Noni biomics for rejuvenating the skin microbiota; Deobiome Noni, a prebiotic deodorant to reduce the generation of body odour; Sarcoslim Re-Shape, an active ingredient to reduce fat on tissue; Capilia Longa that improves density in hair, eyebrows, and eyelashes; and Luminia Granatum that brightens skin, whitens dark spots, evens skin tone, and ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 37
Stock Exchange Madrid Stock Exchange
Ticker Symbol VYT
Full Company Profile

Financial Performance

In 2024, Vytrus Biotech's revenue was 6.09 million, an increase of 29.51% compared to the previous year's 4.70 million. Earnings were 1.02 million, an increase of 87.36%.

Financial Statements

News

There is no news available yet.